Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema (right eye)
ICD-10 E09.3211 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema (right eye).
E09.3211 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by mild nonproliferative diabetic retinopathy with macular edema in the right eye. This condition arises when certain medications, such as corticosteroids or antipsychotics, lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. The presence of mild nonproliferative diabetic retinopathy indicates early changes in the retina due to diabetes, where small blood vessels may leak fluid, leading to macular edema, which can affect vision. Management of this condition typically involves controlling blood glucose levels through lifestyle modifications, oral hypoglycemic agents, or insulin therapy, while also addressing the ocular complications through regular ophthalmologic evaluations and potential treatments such as laser therapy or anti-VEGF injections. Regular monitoring of HbA1c levels is crucial to assess long-term glycemic control and prevent further complications.
Detailed medication history, HbA1c levels, and management plans.
Patients with diabetes management issues due to medication changes.
Ensure clear documentation of drug-induced nature and its impact on diabetes control.
Ocular examination findings, including retinal imaging results.
Patients presenting with vision changes related to diabetic retinopathy.
Document the severity of retinopathy and any treatments administered.
Used for routine eye exams in diabetic patients.
Document visual acuity, retinal findings, and any treatments.
Ensure linkage to diabetes diagnosis for proper billing.
Common medications include corticosteroids, thiazide diuretics, and certain antipsychotics, which can lead to insulin resistance or impaired insulin secretion.
